Sepsis & infection

Interleukin-36 is overexpressed in human sepsis and IL-36 receptor deletion aggravates lung injury and mortality through epithelial cells and fibroblasts in experimental murine sepsis

Crit CarePublished Mechanistic study

Authors' conclusion

Septic patients had elevated serum IL-36 levels, which may correlate with disease severity and mortality. In experimental sepsis, we demonstrated a previously unrecognized role of IL-36R deletion in increasing lethality.

Study context

Population
Septic patients at intensive care unit (ICU) and ED admission; mice with cecal ligation and puncture (CLP)-induced polymicrobial sepsis
Participants
47 / 21 / 21
Comparison
Sepsis vs ICU controls vs Healthy volunteers
  • Sepsisn = 47
  • ICU controlsn = 21reference
  • Healthy volunteersn = 21reference
Outcome
Serum IL-36 level
Follow-up
Day of ICU and ED admission
Methodological detailshuman cohort, murine CLP sepsis model
  • Human cohort
  • Murine CLP sepsis model

Main finding

As reported in the abstract

  • Significantly higher serum IL-36 in sepsis vs ICU controls and healthy volunteers; related to sepsis severity
  • Lower serum IL-36 in non-survivors vs survivors of sepsis
  • High serum IL-36 associated with 28-day mortality; independent predictor by logistic regression
  • IL-36R deletion increased lethality in CLP-induced sepsis

Further findings

Bacterial load and organ injury in septic mice

IL-36R deletion: higher bacterial load and more severe lung, liver and kidney injury

Mechanism

IL-36R ligands released upon lung damage activated IL-36R+ lung fibroblasts, inducing lipocalin 2, and induced lung epithelial cell apoptosis

Original publication

Interleukin-36 is overexpressed in human sepsis and IL-36 receptor deletion aggravates lung injury and mortality through epithelial cells and fibroblasts in experimental murine sepsis. Crit Care. Published 13 December 2023. doi:10.1186/s13054-023-04777-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.